A Study To Investigate The Effectiveness Of AH234844 (Lavoltidine) Compared With NEXIUM And Ranitidine.

NCT00405119 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux Disease
Reflux, Gastroesophageal

Interventions

DRUG: AH23844 (lavoltidine)
DRUG: NEXIUM (esomeprazole)
DRUG: ZANTAC (ranitidine)

Sponsor

GlaxoSmithKline